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Background.  Use of ultrasound to assess peripheral skeletal muscle architecture during 
critical illness is rapidly gaining research popularity but systematic review evidence is 
lacking. 
Objectives.  To critically evaluate and summarize identified evidence for the use of 
ultrasound to measure peripheral skeletal muscle architecture during critical illness. 
Data Sources.  Seven electronic databases (Medline, Cumulative Index to Nursing and Allied 
Health Literature, Cochrane Library, Physiotherapy Evidence Database, Scopus, Excerpta 
Medica Database and Web of Science (including Science Citations and Conference 
Proceedings)), and personal libraries were searched for relevant articles.  Cross-referencing 
further identified references. 
Study selection.  Quantitative study designs excluding abstracts, published in English, 
including adult critically ill patients in the intensive care unit, evaluating peripheral skeletal 
muscle architecture during critical illness with ultrasound.  Studies utilizing ultrasonographic 
muscle data as outcome measures in interventional trials were excluded.     
Data Extraction.  Performed by one reviewer using a standardized data extraction form and 
cross-checked by a second reviewer.  Quality appraisal was undertaken by two independent 
reviewers - studies were classified, graded and appraised according to standardized 
algorithms and checklists.  Preferred Reporting Items for Systematic Reviews and Meta-
Analyses guidelines were adhered to.   
Data Synthesis.  Seven studies with independent patient cohorts totaling 300 participants 
were included.  One study adopted a case-control design, the remainder were case series.  
Ultrasound data demonstrated deficits in a variety of peripheral skeletal muscle architecture 
parameters across a range of muscle groups associated with critical illness.  Ultrasound 
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offered more accurate data compared to limb circumference measurement and has 
excellent reported reliability, but underestimated data acquired via more invasive muscle 
biopsy.   
Conclusion.  Ultrasound provides clinical utility for assessing the trajectory of change in 
peripheral skeletal muscle architecture during critical illness, supplementing more detailed 
characterization, albeit rarely used, from muscle biopsy analysis.  Adoption of standardized 
operating protocols for measurement will facilitate future meta-analysis of data.  
Registration number.  CRD42013004892 (PROSPERO database, available at 



















Peripheral skeletal muscle wasting is a major complication of critical illness.  Described 
clinically as intensive care unit acquired weakness (ICU-AW), it is associated with prolonged 
weaning, delayed rehabilitation, increased hospital length of stay and mortality (1-6) with 
residual deficits in physical functional ability persisting up to five years following the index 
ICU admission (7).  Risk stratification of patients with peripheral muscle wasting is therefore 
vital for optimizing clinical management (8), including delivery of exercise therapy, 
rehabilitation and other therapeutic interventions. 
 
Volitional methods of measuring muscle strength such as manual muscle testing (9), whilst 
clinically appealing, are restricted to alert, awake and cognitively intact patients able to 
produce maximal efforts.  Distinguishing true muscle weakness from poor motivation or 
inability to complete the task is challenging and use of manual muscle testing in the early 
stages of critical illness is limited (10, 11).  Non-volitional techniques involving electrical (12, 
13), or magnetic (14-17) motor nerve stimulation to elicit twitch force responses require no 
patient cooperation but can be technically complex to perform, particularly in the ICU 
environment, requiring expensive dedicated equipment and skilled personnel for 
assessment and interpretation (18).  Consequently, recent attention has focused on the 
utility of ultrasound to monitor the trajectory of muscle wasting in critically ill patients (19).   
 
Principles of the neuromuscular ultrasound technique have been described previously (20-
22), with ultrasonographic differences evident between healthy and diseased skeletal 
muscle (23, 24) and a number of characteristics of peripheral skeletal muscle architecture 
including cross-sectional area, fiber pennation angle, muscle layer thickness and 
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echogenicity measurable (25).  In addition, ultrasound has both pragmatic and clinical 
advantages.  It is widely available across ICUs, and is portable, simple and quick to perform.  
It is also effort-independent, free of ionizing radiation, can be performed at the bedside, and 
with training can be implemented by non-specialist clinicians. 
 
The objective of this systematic review was to critically evaluate and summarize identified 
evidence for the use of ultrasound to measure peripheral skeletal muscle architecture 
during critical illness, and was conducted and reported in line with the Preferred Reporting 




This systematic review was registered on the National Institute for Health Research (NIHR) 
International Prospective Register of Systematic Reviews (PROSPERO) (Registration 
reference CRD42013004892, available at http://www.crd.york.ac.uk/prospero/).   
 
Eligibility criteria 
Study characteristics for eligibility are detailed in Table 1, including participants, 
interventions, control groups and outcome measures.  
 
Information sources 
Confirmation that a review of this nature had not been published or was in progress was 
obtained prior to commencement, from a search of the Cochrane Library, Physiotherapy 
Evidence Database (PEDro) and the NIHR PROSPERO databases. 
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Electronic databases (n=7) were searched by one reviewer (BC) using a systematic detailed 
and reproducible search strategy to identify published evidence (Table 2).  Databases were 
accessed via King’s College London, UK, and included Medline (1946-present), Cumulative 
Index to Nursing and Allied Health Literature (CINAHL) (1981-present), Cochrane Library 
(2013), PEDro (1993-present), Scopus (1960-present), Excerpta Medica Database (EMBASE) 
(1980-present) and Web of Science (including Science Citations and Conference 
Proceedings) (1900-present), with the last search run 16th October 2013.  Full search 
strategies are included in the Supplemental Digital Content (SDC).  Additional references 
were identified by cross-checking reference lists of included articles and searching personal 
libraries of the authors.   
 
Search 
Trial registries, conference proceedings and electronic databases were searched using the 
following terms: intensive care, critical care, critical illness, critically ill, multi-organ failure, 
sepsis, ultrasound, ultrasonography, muscle, muscle wasting, muscle mass, cross-sectional 
area, fiber pennation angle, muscle layer thickness, echo intensity, echogenicity, muscle 
architecture (Table 2). 
 
Study selection 
Figure 1 summarizes the study selection process.  From the initial search, two independent 
reviewers (BC, VM) adopted a standardized approach to assess studies for eligibility against 
predefined eligibility criteria using article titles and abstracts (Table 1).  In the absence of 
sufficient detail to inform decision-making, full texts were sourced and the process 
repeated.  In the event of disagreement, a consensus approach was taken to reach a 
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decision.  A third reviewer (NH) was employed to make the final decision if this could not be 
achieved.  At each stage, level of agreement was determined using percentage agreement 
and Kappa statistic (SPSS for Windows, Statistical Version 20, IBM, New York, NY).  All 
references were stored in Endnote software, Version 6 (Thomson Reuters, Philadelphia, PA).   
 
Data extraction 
Using a bespoke data collection form, data extraction from included studies was performed 
by one reviewer (BC) and cross-checked by a second (AL).  Data were stored in either 
Microsoft Excel or Word for PC 2007 (Windows 7, Microsoft Corporation, Redmond, WA). 
 
Data items 
Data extraction was conducted on all eligible studies including: 1) study design – type, 
author first name and country, publication journal and year, aim/objective; 2) participant 
characteristics; 3) ultrasound detail – timing of measurement, muscle groups and muscle 
architecture characteristics assessed, detail of technique, and results. 
 
Risk of bias in individual studies 
Two independent reviewers (BC, VM) assessed included studies.  Study design was 
determined using a published classification algorithm from the Scottish Intercollegiate 
Guidelines Network (SIGN) and the National Institute for Health and Care Excellence with 
associated relevant checklists employed to assess study quality (27, 28).  Studies were 
graded according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence (29).  
In addition methodological quality and risk of bias in randomized controlled trials (RCTs) 
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were determined using the PEDro scale (30), and the Newcastle-Ottowa Scale (NOS) (31) for 




Searching of the seven databases resulted in 672 potentially eligible studies, with a further 
11 articles identified through cross-referencing and personal libraries (Figure 1).  Studies not 
published in English were excluded (n=1).  Two conference proceedings were checked but 
no relevant studies identified.  For the remaining conference abstracts (n=10), two studies 
within the author’s own library contained data pertaining to four of these.  Authors of a 
further two abstracts were contacted to determine if data were available in peer-reviewed 
publication format, following which neither study was included.  No contact was made with 
the remaining four abstract authors as data had been collected in non-ICU settings (n=2), in 
healthy subjects (n=1) or no email address or other contact details were available (n=1). 
  
High levels of agreement between the two independent reviewers were evident for 
potentially relevant titles and abstracts (percentage agreement=90.2%, Kappa=0.72) and 
full-text articles (percentage agreement=100.0%, Kappa 1.0).  The reviewers disagreed on 
four potentially eligible studies based on title and abstract.  Following consensus, agreement 
was reached on all four studies and no study was included.  Input from a third reviewer was 
not required.  Review of title, abstract and full text resulted in the inclusion of seven original 





Study design characteristics are summarized in Table 3.  None of the seven included studies 
(32-38) were randomized controlled trials.  Six were primarily single group studies, classified 
as case series (33-38).  One of these studies involved comparison with an unmatched control 
group (35).  The final study adopted a case-control design (32).  All studies were Level 4 
evidence grade (29).  Significantly, the majority of included studies were published between 
2012 and 2013 (32, 34, 35, 37) indicating the emerging research interest in ultrasound as a 
technique for evaluating peripheral skeletal muscle architecture during critical illness.  Five 
studies were European (33, 35-37, 39), with one conducted in Australia (32) and one in 
North America (34).  Patient characteristics of included studies are reported in Table 4.   
 
Of the seven studies included, each involved independent general ICU patient populations, 
overall totaling 300 patients, where the primary purpose involved assessment of peripheral 
skeletal muscle function during critical illness with ultrasound as the evaluation tool.  
Sample sizes ranged between 9 (33) and 118 (36) patients.  Eligible patient populations in 
studies were characterized according to either clinical diagnostic descriptors (e.g. multi-
organ failure and sepsis) (33-35), ICU admission-related descriptors (e.g. duration of 
mechanical ventilation and length of stay) (36, 37), or a combination of both (32, 38).   Only 
four studies reported actual illness severity of their patient cohorts using standard critical 
care scoring systems (APACHE) scores) (32, 35, 37, 38), of which three further reported 
actual duration of mechanical ventilation for their patient cohorts (32, 35, 37).   
 
Muscle thickness was the most common characteristic of muscle architecture evaluated 
(five studies) (32-34, 36, 38) (SDC, Table 1).  In one study this was termed muscle layer 
thickness and used to reflect muscle mass (36).  Muscle composition using echogenicity was 
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investigated in two studies (34, 35), and cross-sectional area in one (37).  A combination of 
mid-upper arm, forearm and thigh muscle groups were all measured in four studies (32, 33, 
35, 38).  In addition, tibialis anterior and abductor digiti minimi muscle were also reported 
(34, 35).  Quadriceps muscle alone was measured in two studies (36, 37).  Details of 
measurement procedure were provided in all studies.  Timings of measurements varied 
between single measurements performed at specific time-points during ICU admission (32, 
34-37), or sequentially throughout the duration of ICU admission (33, 38).  
 
Results of Individual Studies 
Change in muscle architecture of critically ill patients was evident in six studies and 
associated with duration of time in the ICU (33-38) (SDC, Table 2).  In the remaining case-
control study, muscle thickness was found to be significantly reduced compared to case-
controlled healthy subjects at the single time-point assessed (32).  Rates of reported muscle 
wasting varied between 6.0% per day (33) and 1.6% per day, with more notable wasting in 
patients with greater muscle layer thickness at baseline (38).  A third study reported a 12.5% 
reduction between days 1 and 7, which further differed significantly between those with 
single and multiple organ failure (37).  A quantifiable measurement of degree of muscle 
wasting was not given in one study (36).  Muscle quality (echogenicity) was shown to be 
affected during critical illness with increases in image grey-scale values (34, 35), which were 
significantly different to healthy controls, albeit an unmatched population (35).  Three 
studies reported high levels of ultrasound image reproducibility in critically ill patients 
(intraclass correlation coefficients (ICC) >0.9), for inter-image (muscle thickness and muscle 
echogenicity) (32, 35), intra-rater (muscle echogenicity) (35) and inter-observer (muscle 
cross-sectional area) (37) agreement.  Reid et al (38) also presented reproducibility data, 
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reporting a coefficient of variation (CV) for total muscle thickness of 2.5% although this was 
in a separate cohort of healthy volunteers rather than their ICU patient cohort.  Similarly, 
Campbell et al (33) reported an intra-observer CV of 1.5% and an inter-observer CV of 1.9% 
for total muscle thickness in a cohort of healthy subjects assessed within their study.   
 
Risk of bias within studies 
Two independent reviewers (BC and VM) agreed on the study design of included studies 
(percentage agreement=100%).  Due to the nature of study design assigned to the majority 
of studies (n=6, case series) involving single groups of patients receiving ultrasound 
measurements of peripheral skeletal muscle architecture during critical illness, no tool was 
available to assess risk of bias in these studies (27).  The reviewers considered that the 
design of one of the studies (35) involving comparison with an unmatched control group did 
not meet the criteria for categorization as a case-controlled study with associated quality 
review.  The single identified case-controlled study (Baldwin et al (32)) demonstrated 
positive scoring on seven out of eleven binary outcome criteria, according to the SIGN 
checklist (63.6%), and percentage agreement of 84.6%, however no grading system exists to 
equate this to an overall descriptor of quality level (27).  This article scored 6 on the NOS 
indicating ‘good’ overall quality (31). 
 
Synthesis of results 
Meta-analysis or pooling of results was not appropriate due to the observational nature and 
design of studies included, heterogeneity of patient cohorts, and varying results related to 





This systematic review identified and included seven studies evaluating the effect of critical 
illness on peripheral skeletal muscle architecture assessed using ultrasound.  Each study 
reported a general ICU population in patients presenting with sepsis and multi-organ failure 
with ICU lengths of stay of at least seven days.  Changes in a range of muscle architecture 
parameters were reported across a range of muscle groups, with ultrasound assessment 
demonstrating clinical reliability and utility. 
 
Significance of findings 
Ultrasound data characterized the negative effects on peripheral skeletal muscle 
architecture associated with acute critical illness.  Nonetheless, meta-analyses of data were 
not possible due to variability in muscle group and architecture parameter assessed, study 
protocols, and the extent and clarity of data reporting.  Hence consideration of confounding 
factors such as age, illness acuity or nutritional management on muscle architecture during 
critical illness was limited.   
 
Five studies measuring muscle thickness (32-34, 36, 38) produced varying results, possibly 
contributed to by inconsistency in baseline measurement point resulting in an 
underestimation of muscle wasting during ICU admission.  Three of these analyzed total 
muscle thickness, calculated as the average across a variety of muscle groups (33, 36, 38).  
The remaining two studies reported, but did not compare, muscle thicknesses for individual 
muscles, (32, 34).  As a result, the relative degree and significance in distribution of 
peripheral skeletal muscle wasting was unknown.  Muscle echogenicity increased in two 
studies, albeit measured using different methods, suggesting presence of myopathic 
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changes in the muscle during critical illness possibly due to edema from capillary leak during 
acute sepsis with loss of the typically organized muscle architecture occurring during 
breakdown (34, 35).  Biopsy data from our own group, from days 1 and 7 of ICU admission, 
confirmed this, demonstrating muscle necrosis and macrophage cellular infiltrate (37).  
Finally, no study reported measurement of fiber pennation angle, which in combination 
with anatomical cross-sectional area values allows calculation of physiological cross-
sectional area, in turn associated with the force-generating capacity of a muscle (25).  The 
clinical advantages of this potentially more complex parameter require further investigation. 
 
The relationship between muscle wasting in critically ill patients and functional outcome 
was not investigated in any studies.  Clinically significant muscle loss has yet to be defined, 
even when changes are at a statistical level.  Strength correlates with peripheral muscle 
cross-sectional area in healthy subjects and patients with chronic co-morbidity (13, 40-42), 
albeit there are few data for critically ill patients.  Ideally, contemporaneous measures of 
muscle force would validate ultrasound measures of peripheral skeletal muscle architecture, 
and which could then be mapped to levels of physical functional ability. 
 
Technical considerations of ultrasound 
Ultrasound measurements were feasible across all patients in all studies with the exception 
of two circumstances.  Puthucheary et al (37) reported one patient unable to complete 
assessment of quadriceps rectus femoris cross-sectional area due to morbid obesity, and 
diaphragm echotexture was not assessed by Cartwright et al (34) as the muscle was too thin 
for accurate measurement.  High reliability of the ultrasound technique was evident in three 
included studies (32, 35, 37).   
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 All studies reported technical detail of ultrasound measurement including make and model 
of machine and transducer specification.  However, there was a lack of reported detail 
regarding image acquisition settings e.g. scanning depth or gain.  Furthermore, despite 
commonality in a number of muscle groups assessed, variation was evident in patient 
position and probe location on the muscle group.  Whilst protocol standardization within 
studies provides internal validity for the use of ultrasound as a tool for monitoring change in 
muscle architecture, variation across studies limited pooling of data to determine overall 
effect and influences external validity.   
 
Ultrasound findings all indicated superiority over results of limb circumference, where 
performed, due to the confounding problem of subcutaneous edema influencing 
measurement accuracy.  Typically whilst muscle cross-sectional area or thickness decreased, 
limb circumference remained unchanged (33, 36, 38).  Ultrasound measures of muscle 
architecture have also been shown to correlate closely with data obtained via magnetic 
resonance imaging (43) and computed tomography (41) scanning modalities, supporting 
clinical benefit over techniques that are more costly, time-consuming and involve radiation.  
Although these data originate from healthy subjects or stable patients with chronic co-
morbidity, they are nonetheless valuable as conducting similar studies in critically ill patients 
has limited feasibility.   
 
However, additional investigation by Puthucheary et al (37) highlighted a limitation in 
ultrasound data interpretation.  A subset of their cohort underwent additional measures of 
muscle wasting, including quadriceps vastus lateralis muscle biopsy and quantification of 
protein to deoxyribonucleic acid (DNA) ratio.  Ultrasound of muscle cross-sectional area not 
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only underestimated fiber cross-sectional area, but also actual loss in muscle mass with the 
greatest reduction observed in the protein/DNA ratio over the 10 day study period.  Indeed, 
as the protein/DNA ratio is unaffected by water content of the muscle and these data 
strongly support the observation that quadriceps rectus femoris ultrasound underestimated 
muscle loss as a consequence of muscle oedema.  Evaluation of muscle composition using 
grey-scale analysis may assist in determining level of intramuscular fluid to provide a 
clinically applicable assessment of muscle quality, albeit further validation of echogenicity 
findings is required.  The additional analyses undertaken by Puthucheary et al (37) were 
invasive, costly, required expertise to conduct, analyze and interpret and these invasive 
measurements were only feasible in a very select patient group.  As previously described, 
ultrasound demonstrates advantages in all these areas and these data should not detract 
from the clinical utility of the tool.   
 
Critique of the method 
This systematic review was conducted and reported in line with PRISMA guidelines (26), 
specifically identifying studies primarily evaluating peripheral skeletal muscle architecture 
during critical illness using ultrasound.  Data regarding respiratory musculature changes 
were excluded, including from two eligible studies (34, 44).  However, this topic has recently 
been reported in two comprehensive reviews (45, 46), with growing evidence documenting 
diaphragm atrophy during critical illness and weaning from mechanical ventilation (32, 34, 
47-49).  Furthermore, interventional trials using change in peripheral skeletal muscle 
architecture as an outcome measure were also excluded.  The majority of these related to 
electrical stimulation for preservation of muscle mass during critical illness (50-54), itself 
also the topic of a recent, more focused systematic review (55).  That the current review 
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failed to identify all studies reported by Parry et al (55), highlights the pragmatic limitations 
of robustly identifying all potential interventional trials where peripheral skeletal muscle 
architecture measured using ultrasound could be an outcome measure.  Prior knowledge of 
the intervention would be required to facilitate database searching using relevant indexing 
terms.  
 
We included studies based only within the ICU, focusing on early critical illness.  Two 
sources of excluded evidence and one included study reported ultrasound data of 
peripheral skeletal muscle architecture following ICU discharge on the ward (56), up to 6 
(34) and 12months post discharge (39) suggesting utility of the technique for longitudinal 
monitoring of the trajectory of recovery of peripheral skeletal muscle architecture following 
critical illness.  This could further assist in identifying the optimum time for delivery of 
exercise-based rehabilitation interventions following hospital discharge.    
 
We acknowledge potential publication bias through database searching that may have 
excluded non-peer-reviewed publications.  Despite this, our chosen databases were wide-
ranging and identified conference proceedings and other citations.  We did not search 
clinical trial registries due to the observational nature of the review topic.  As per usual, data 
available in abstract form only were excluded due to lack of technical detail provided in 
these summaries, and this accounted for only one item.  Mampilly et al (57) reported 
reduced rectus femoris cross-sectional area values for critically ill patients compared to 
healthy subjects (n=5 each group; 4.5 ± 0.6cm2 vs. 10.1 ± 0.8cm2, p<0.002), but similar to 




We adhered to recognized classification algorithms for determining study design (27) and 
we acknowledge the majority of included studies were non-comparative case series.  Whilst 
this is perhaps not unsurprising given the observational nature and purpose of the review, 
there was no tool available to assess the quality of these studies, which is a limiting factor to 
their methodological robustness. 
 
Future considerations 
Currently, there is no gold standard for the measurement of peripheral skeletal muscle 
architecture using ultrasound, and this review demonstrates a variety of parameters 
employed in the critical illness population.  Further work is necessary to determine 
uniformity of technical application.  Minimum reporting detail would include make and 
model of machine, probe specification, image acquisition settings, and precise description of 
patient position and location on the muscle for measurement.  Inclusion of standard 
operating protocols as supplementary materials to data publication would strongly facilitate 
future consensus on this.  Future studies are required to determine the relationship 
between ultrasound measurements, both single and sequential measurements, and 




Ultrasound is gaining in profile as a tool for evaluating changes in peripheral skeletal muscle 
architecture during critical illness.  Whilst the technique has been shown to underestimate 
the extent of muscle wasting obtained from invasive muscle biopsy techniques, its practical 
and clinical advantages, when supplemented with data demonstrating high levels of 
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reliability, strongly confirm the clinical utility of ultrasound.  Further investigation with 
regards to muscle composition using grey-scale analysis of images will assist in 
corroborating detailed muscle biopsy data.  Standardization of protocol detail will improve 
external validity for performance of future studies, and permit future meta-analysis of data 
and investigation of confounding factors associated with alteration of peripheral skeletal 






















1. Ali NA, O'Brien JM, Jr., Hoffmann SP, et al. Acquired Weakness, Handgrip Strength, 
and Mortality in Critically Ill Patients. Am J Resp Crit Care Med 2008;178(3):261-268. 
2. De Jonghe B, Bastuji-Garin S, Durand M-C, et al. Respiratory weakness is associated 
with limb weakness and delayed weaning in critical illness Crit Care Med 2007;35(9):2007-
2015. 
3. De Jonghe B, Sharshar T, Lefaucheur J-P, et al. Paresis Acquired in the Intensive Care 
Unit. JAMA 2002;288(22):2859-2867. 
4. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia J, et al. Effect of critical 
illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay 
in septic patients. Crit Care Med 2005;33(2):349-354. 
5. Leijten F, Harinck-de Weerd J, Poortvliet D, et al. The Role of Polyneuropathy in 
Motor Convalescence After Prolonged Mechanical Ventilation. JAMA 1995;274(15):1221-
1225. 
6. Sharshar T, Bastuji-Garin S, Stevens RD, et al. Presence and severity of intensive care 
unit-acquired paresis at time of awakening are associated with increased intensive care unit 
and hospital mortality. Crit Care Med 2009;37(12):3047-3053. 
7. Herridge MS, Tansey CM, Matté A, et al. Functional Disability 5 Years after Acute 
Respiratory Distress Syndrome. N Engl J Med 2011;364(14):1293-1304. 
8. Puthucheary Z, Hart N. Intensive care unit acquired muscle weakness: when should 
we consider rehabilitation? Crit Care 2009;13(4):167. 
9. Vanpee G, Hermans G, Segers J, et al. Assessment of Limb Muscle Strength in 
Critically Ill Patients: A Systematic Review. Crit Care Med 2014;42(3):701-711. 
21 
 
10. Connolly B, Jones G, Curtis A, et al. Clinical predictive value of manual muscle 
strength testing during critical illness: an observational cohort study. Critical Care 
2013;17(5):R229. 
11. Hough C, Lieu B, Caldwell E. Manual muscle strength testing of critically ill patients: 
feasibility and interobserver agreement. Critical Care 2011;15(1):R43. 
12. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical 
illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg 
Psychiatry 2008;79(7):838-841. 
13. Seymour JM, Ward K, Raffique A, et al. Quadriceps and ankle dorsiflexor strength in 
chronic obstructive pulmonary disease. Muscle and Nerve 2012;In 
Press(10.1002/mus.23353). 
14. Harris M, Lou Y, Watson A, et al. Adductor Pollicis Twitch Tension Assessed by 
Magnetic Stimulation of the Ulnar Nerve. Am J Respir Crit Care Med 2000;162(1):240-245. 
15. Harris M, Moxham J. Measuring respiratory and limb muscle strength using magnetic 
stimulation. British Journal of Intensive Care 1998;8:21-28. 
16. Polkey MI, Kyroussis D, Hamnegard CH, et al. Quadriceps strength and fatigue 
assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 
1996;19(5):549-555. 
17. Watson A, Hughes P, Harris L, et al. Measurement of twitch transdiaphragmatic, 
esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic 
nerve stimulation in patients in the intensive care unit. Crit Care Med 2001;29(7):1325-
1331. 
18. Schweickert WD, Hall J. ICU-acquired weakness. Chest 2007;131(5):1541-1549. 
22 
 
19. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: 
wasting, weakness, and rehabilitation strategies. Crit Care Med 2010;38(10 Suppl):S676-682. 
20. Pillen S. Skeletal muscle ultrasound. European Journal of Translational Myology 
2010;1(4):145-155. 
21. Pillen S, Arts IMP, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle 
Nerve 2008;37(6):679-693. 
22. Walker FO, Cartwright MS, Wiesler ER, et al. Ultrasound of nerve and muscle. Clin 
Neurophysiol 2004;115:495-507. 
23. Chi-Fishman G, Hicks J, Cintas H, et al. Ultrasound imaging distinguishes between 
normal and weak muscle. Arch Phys Med Rehabil 2004;85:980-986. 
24. Heckmatt J, Dubowitz V, Leeman S. Detection of pathological change in dystrophic 
muscle with B-scan ultrasound imaging. Lancet 1980;1:1389-1390. 
25. Lieber RL. Skeletal Muscle Structure, Function, and Plasticity: The Physiological Basis 
of Rehabilitation. Third ed. Philadelphia, US: Lippincott Williams & Wilkins; 2010. 
26. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting 
systematic reviews and meta-analyses of studies that evaluate healthcare interventions: 
explanation and elaboration. BMJ 2009;339:b2700. 
27. SIGN 50: A guideline developer's handbook. Scottish Intercollegiate Guidelines 
Network  Accessed 26/10/13;Available at 
http://www.sign.ac.uk/guidelines/fulltext/50/section10.html. 
28. NICE. NICE Guideline Development Methods. London; 2004. 
29. OCEBM. Levels of Evidence Working Group. Oxford Centre for Evidence-Based 
Medicine  Accessed 18/05/13;Available at http://www.cebm.net/index.aspx?o=5653. 
23 
 
30. Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro Scale for Rating 
Quality of Randomized Controlled Trials. Phys Ther 2003;83(8):713-721. 
31. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing 
the quality of nonrandomised studies in meta-analyses. Accessed 18/05/13;Available at 
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 
32. Baldwin CE, Bersten AD. Alterations in Respiratory and Limb Muscle Strength and 
Size in Patients With Sepsis Who Are Mechanically Ventilated. Phys Ther 2014;94:68-82. 
33. Campbell IT, Watt T, Withers D, et al. Muscle thickness, measured with ultrasound, 
may be an indicator of lean tissue wasting in multiple organ failure in the presence of 
edema. Am J Clin Nutr 1995;62(3):533-539. 
34. Cartwright MS, Kwayisi G, Griffin LP, et al. Quantitative Neuromuscular Ultrasound in 
the Intensive Care Unit. Muscle and Nerve 2013;47:255-259. 
35. Grimm A, Teschner U, Porzelius C, et al. Muscle ultrasound for early assessment of 
critical illness neuromyopathy in severe sepsis. Critical Care 2013;17:R227. 
36. Gruther W, Benesch T, Zorn C, et al. Muscle wasting in intensive care patients: 
ultrasound observation of the M. quadriceps femoris muscle layer. Journal of Rehabilitation 
Medicine 2008;40(3):185-189. 
37. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical 
illness. JAMA 2013;310(15):1591-1600. 
38. Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. 
Clin Nutr 2004;23(2):273-280. 
39. Reid C, Murgatroyd P, Wright A, et al. Quantification of lean and fat tissue repletion 
following critical illness: a case report. Critical Care 2008;12(3):1-6. 
24 
 
40. Narici MV, Landoni L, Minetti AE. Assessment of human knee extensor muscles stress 
from in vivo physiological cross-sectional area and strength measurements. Eur J Appl 
Physiol 1992;65(5):438-444. 
41. Seymour JM, Ward K, Sidhu PS, et al. Ultrasound measurement of rectus femoris 
cross-sectional area and the relationship with quadriceps strength in COPD. Thorax 
2009;64(5):418-423. 
42. Thomaes T, Thomis M, Onkelinx S, et al. Reliability and validity of the ultrasound 
technique to measure the rectus femoris muscle diameter in older CAD-patients. BMC 
Medical Imaging 2012;12:7. 
43. Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of human 
skeletal muscle size. European Journal of Applied Physiology 2004;91(1):116-118. 
44. Baldwin CE, Paratz JD, Bersten AD. Diaphragm and peripheral muscle thickness on 
ultrasound: intra-rater reliability and variability of a methodology using non-standard 
recumbent positions. Respirology 2011;16(7):1136-1143. 
45. Matamis D, Soilemezi E, Tsagourias M, et al. Sonographic evaluation of the 
diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med 
2013;39(5):801-810. 
46. Sarwal A, Walker F, Cartwright M. Neuromuscular ultrasound for evaluation of the 
diaphragm. Muscle and Nerve 2013;47:319-329. 
47. Giraldo SR, Lecaros LE. Ultrasound evaluation of diaphragm muscle in patients with 
failed and succesful weaning. Crit Care Med 2011;39:12 (Suppl), 90. 
48. Lee Y, Grosu H, Lee J, et al. Diaphragm muscle atrophy in the mechanically ventilated 
patients. Chest 2011;140 (4):413A. 
25 
 
49. Lerolle N, Diehl JL. Ultrasonographic evaluation of diaphragmatic function. Crit Care 
Med 2011;39(12):2760-2761. 
50. Carkner JJ, Murphy G, Bourbeau J, et al. Neuromuscular electrical stimulation 
improves lower-limb strength after long-term bedrest: Case study in a mechanically-
ventilated intensive care patient. Am J Respir Crit Care Med 2011;183 A4242. 
51. Rodriguez PO, Setten M, Maskin LP, et al. Muscle weakness in septic patients 
requiring mechanical ventilation: Protective effect of transcutaneous neuromuscular 
electrical stimulation. J Crit Care 2012;27(3):319.e311-318. 
52. Gerovasili V, Stefanidis K, Vitzilaios K, et al. Electrical muscle stimulation preserves 
the muscle mass of critically ill patients: a randomized study. Critical Care 2009;13(5):R161. 
53. Gruther W, Kainberger F, Fialka-Moser V, et al. Effects of Neuromuscular Electrical 
Stimulation on Muscle Layer Thickness of Knee Extensor Muscles in Intensive Care Unit 
Patients: a Pilot Study. Journal of Rehabilitation Medicine 2010;42:593-597. 
54. Mampilly J, Hammond K, Laghi F, et al. Effect Of Neuromuscular Electrical 
Stimulation In Preserving Muscle Function In ICU Patients Requiring Mechanical Ventilation. 
Am J Respir Crit Care Med 2011;315:A2720. 
55. Parry S, Berney S, Granger C, et al. Electrical Muscle Stimulation in the Intensive Care 
Setting: A Systematic Review. Crit Care Med 2013;41(10):2406-2418. 
56. Connolly B, Moxham J, Hart N. Relationship between quadriceps rectus femoris 
cross-sectional area and health related quality of life in patients following critical illness. 
Thorax 2011;66:A97. 
57. Mampilly J, Yazicioglu-Mocin O, Manley C, et al. Assessment of muscle wasting in ICU 





Figure 1.  Flow diagram summarizing article selection 
Abbreviations: CINAHL = Cumulative Index to Nursing and Allied Health Literature.  EMBASE = Excerpta Medica 
Database.  PEDro = Physiotherapy Evidence Database.  ICU = intensive care unit.  US = ultrasound. 
 
